Cisplatin: a review of clinical applications and renal toxicity
- PMID: 3909096
- DOI: 10.1007/BF01959196
Cisplatin: a review of clinical applications and renal toxicity
Abstract
In reviewing the literature about the clinical application of cis-diamminedichloroplatinum(II) (cisplatin) it can be concluded that the availability of cisplatin has been an important advance in cancer chemotherapy; especially in patients with disseminated testicular carcinoma and ovarian cancer cisplatin-based combinations are the first choice treatment. Our own investigations of the nature of the main form of toxicity of cisplatin, the nephrotoxicity, are mentioned and methods of its prevention are summarized.
Similar articles
-
Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.Cancer Chemother Pharmacol. 2008 May;61(6):903-9. doi: 10.1007/s00280-008-0711-0. Epub 2008 Mar 4. Cancer Chemother Pharmacol. 2008. PMID: 18317762 Review.
-
The influence of aminoglycosides on the nephrotoxicity of cis-diamminedichloroplatinum in cancer patients.J Infect Dis. 1983 Feb;147(2):363. doi: 10.1093/infdis/147.2.363. J Infect Dis. 1983. PMID: 6681828 No abstract available.
-
Cis-diamminedichloroplatinum (NSC-119875): a phase I study.Cancer Chemother Rep. 1973 Nov-Dec;57(4):459-63. Cancer Chemother Rep. 1973. PMID: 4586953 Clinical Trial. No abstract available.
-
[Prevention of cisplatin nephrotoxicity in cancer: adjusting the dosage with a computerized chrono-pump].C R Seances Soc Biol Fil. 1989;183(3):263-8. C R Seances Soc Biol Fil. 1989. PMID: 2532561 French.
-
[Can cisplatin renal toxicity be prevented?].Nephrologie. 1991;12(3):143-6. Nephrologie. 1991. PMID: 1922654 Review. French.
Cited by
-
A biocompatible in vivo ligation reaction and its application for noninvasive bioluminescent imaging of protease activity in living mice.ACS Chem Biol. 2013 May 17;8(5):987-99. doi: 10.1021/cb3007314. Epub 2013 Mar 29. ACS Chem Biol. 2013. PMID: 23463944 Free PMC article.
-
Cancer risk from inorganics.Cancer Metastasis Rev. 1987;6(2):113-54. doi: 10.1007/BF00052846. Cancer Metastasis Rev. 1987. PMID: 2439222 Review.
-
Inhibition of autophagy using 3-methyladenine increases cisplatin-induced apoptosis by increasing endoplasmic reticulum stress in U251 human glioma cells.Mol Med Rep. 2015 Aug;12(2):1727-32. doi: 10.3892/mmr.2015.3588. Epub 2015 Apr 1. Mol Med Rep. 2015. PMID: 25846607 Free PMC article.
-
HIF1α regulated expression of XPA contributes to cisplatin resistance in lung cancer.Carcinogenesis. 2012 Jun;33(6):1187-92. doi: 10.1093/carcin/bgs142. Epub 2012 Mar 31. Carcinogenesis. 2012. PMID: 22467238 Free PMC article.
-
Platinum antitumour agents: a review of (bio)analysis.Pharm Weekbl Sci. 1992 Jun 19;14(3):61-77. doi: 10.1007/BF01962689. Pharm Weekbl Sci. 1992. PMID: 1630874 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical